Form 4 for CVS CVS Health
Accepted 2026-04-02 16:51:16 ET · period of report 2026-03-31 · accession 0000064803-26-000036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-02 16:51 | 2026-03-31 | CVS | Clark James David | SVP, Cont, Chief Acct Off | A - Grant | $71.82 | +11.1K | 35.5K | +46% | +$799.9K |
| D | 2026-04-02 16:51 | 2026-04-01 | CVS | Clark James David | SVP, Cont, Chief Acct Off | F - Tax | $72.49 | -3,262 | 15.5K | -17% | -$236.5K |
| D | 2026-04-02 16:51 | 2026-03-31 | CVS | Clark James David | SVP, Cont, Chief Acct Off | A - Grant | $71.82 | +12.0K | 12.0K | New | +$860.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (Restricted) | 2026-03-31 | A | A | 11,138 | $71.82 | 35,539 | D | — | — | (F1) Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027. |
| 2 | Common | Common Stock | 2026-04-01 | F | D | 3,262 | $72.49 | 15,457 | D | — | — | (F2) Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. |
| 3 | Derivative | Stock Option | 2026-03-31 | A | A | 11,976 | $71.82 | 11,976 | D | $71.82 · 2027-03-31 to 2036-03-31 | 11,976 Common Stock | (F3) Option becomes exercisable in three equal annual installments, commencing 3/31/2027. |